Every AI newsletter, investors ask questions on the investor interaction platform: are the company’s products applied to the prevention and treatment of Helicobacter pylori?
Yue Jiangxi Wannianqing Cement Co.Ltd(000789) (301111. SZ) said on the investor interaction platform on January 7 that the application scope of the company’s products covers 13 drug application fields such as biliary tract, hypoglycemic, heat clearing and detoxification. Please pay attention to the product instructions for specific indications.
(source: Daily Economic News)
